Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity

Published:2019-06-26 Issue:1 Volume:47 Page:2593-2604
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Khanifar Jaleh¹,Salmanian Ali Hatef²,Haji Hosseini Reza¹,Amani Jafar³,Kazemi Rohoallah⁴

Affiliation:

1. Department of Biology, Payame Noor University, Tehran, Iran;

2. Department of Agricultural Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran;

3. Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran;

4. Department of Molecular Biology, Green Gene Company, Tehran, Iran

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://tandfonline.com/doi/pdf/10.1080/21691401.2019.1629947

Reference49 articles.

1. Transmission and control of Escherichia coli O157:H7 — A review

2. Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition

3. Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection

4. Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodegradable nanoplatforms for antigen delivery: part I – state of the art review of polymeric nanoparticles for cancer immunotherapy;Expert Opinion on Drug Delivery;2024-09-08

2. Advances of nanoparticles in transmucosal drug delivery;Nano Research;2023-11-21

3. Protective immunization against Enterohemorrhagic Escherichia coli and Shigella dysenteriae Type 1 by chitosan nanoparticle loaded with recombinant chimeric antigens comprising EIT and STX1B-IpaD;Microbial Pathogenesis;2023-11

4. Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB/c mice;BMC Cancer;2023-02-09

5. Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms;Biosafety and Health;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3